Columbia U Study: Five-fold Increase Rx of Antipsychotics for children
This is documented evidence of major medical malpractice.
This is documented evidence of major medical malpractice.
An investigative report in The Philadelphia Inquirer examined pharmaceutical company ties to six, tax exempt organziations that identify themselves as “patient advocacy” groups, "Each a leading advocate for patients in a disease area.”
A front page article in The New York Times gives a ray of hope about reclaiming medicine from the clutches of industry and its single-minded profit-driven goals:
ABC News reports that antipsychotic drugs are being tested on toddlers at Harvard University affiliate hospital, Massachusetts General Children’s Hospital. Post your comments at: http://blogs.abcnews.com/theblotter/2006/05/tots_used_as_hu.html
"I trusted the doctors, I trusted the FDA … and I feel betrayed by both," says Erin Evans, the mother of Rex who was prescribed the ‘atypical’ antipsychotic, Risperdal (risperidone) at age 8.
When the Times refers to an experiment as "bold and controversial" the reporter is sanitizing the fact that the experiment is UNETHICAL—it violates medicine’s cardinal rule "First, do no harm."
SAMHSA Director: “The New Freedom Commission (NFC) report is not official Bush Administration policy, but rather the unofficial recommendations of an appointed commission.”
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
Psychiatry’s professional practice paradigm has received a major blow.
A report in The New Scientist, "Prescribing of Hyperactivity Drugs is Out of Control," shows just how deviant U.S. prescribing of psychostimulants for
children is compared to the rest of the world.
“Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?” An article in the Schizophrenia Bulletin, by Dr. John Bola that dares to question the validity of the unexamined treatment paradigm in schizophrenia:
AHRP Urges Actions to Minimize Risks for Children prescribed psychotropic drugs: Action is needed to protect children from widespread prescribing of psychoactive drugs for ill-defined behavioral symptoms.